Bill Snyder
-
VU researchers report G protein advancement that could lead to more effective drugs
Thanks in part to a computer program named “Rosetta,” Vanderbilt University researchers are closer to understanding how the ubiquitous G protein is activated – a discovery that could lead to the design of more specific and effective drugs. Read MoreDec 2, 2013
-
Vanderbilt celebrates 18 elected fellows of the AAAS
Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read MoreNov 25, 2013
-
Winder named associate director of MSTP program
Danny Winder, Ph.D., professor of Molecular Physiology and Biophysics, has been appointed associate director of the Vanderbilt Medical Scientist Training Program (MSTP), which enables future leaders in academic medicine to earn both M.D. and Ph.D. degrees. Read MoreNov 21, 2013
-
Diabetes Center to celebrate major milestones
The Vanderbilt Diabetes Center is celebrating two significant milestones this month. Read MoreNov 14, 2013
-
Community Research Day brings area agencies together
The first Community Research Day, sponsored by the Meharry-Vanderbilt Alliance and the Meharry-Vanderbilt Community-Engaged Research Core, was held Tuesday at the MetroCenter headquarters of United Way of Metropolitan Nashville. Read MoreNov 7, 2013
-
Framingham Heart director to speak at VU
Daniel Levy, M.D., director of the famed Framingham Heart Study, will deliver the seventh annual Meredith S. and John A. Oates Lecture in Clinical Pharmacology on Thursday, Nov. 14. Read MoreNov 7, 2013
-
Grant bolsters HIV pharmacy support program
The Vanderbilt Comprehensive Care Clinic has received a nearly $40,000 grant for 2013-2014 from the Baptist Healing Trust (BHT) for its Pharmacy Support Program, which provides free or low-cost medications to people with HIV/AIDS. Read MoreNov 7, 2013
-
Pioneers of Discovery: Investigator driven to divine cellular ecosystem’s rulebook
Ken Lau, Ph.D., a new assistant professor in Cell and Developmental Biology, is out to determine the rules that lead to cells converting from one type to another, for example, when a healthy cell becomes a cancer cell. Read MoreOct 31, 2013
-
VU ‘crosslinks’ study sheds light on chemical toxicity
Vanderbilt researchers have characterized the chemical structures of a series of DNA-protein “crosslinks” that may lead to better ways to avoid the cancer-causing potential of environmental chemicals and prevent some drug toxicities. Read MoreOct 31, 2013
-
Grad students help achieve key discovery
A multidisciplinary study conducted by the combined efforts of Vanderbilt University graduate students has led to the first evidence that abnormal messenger RNA export from the nucleus to the cytoplasm can cause human disease. Read MoreOct 24, 2013
-
Study sheds new light on type 2 diabetes development
Inactivation by oxidative stress of specific transcription factors essential for pancreatic islet beta cell function is a key event in the development of type 2 diabetes, Vanderbilt University researchers and their colleagues have found. Read MoreOct 24, 2013
-
Frisse, Weiner elected to Institute of Medicine
Vanderbilt University’s Betsy Weiner, Ph.D., R.N., senior associate dean for Informatics in the School of Nursing, and Mark Frisse, M.D., MS, MBA, Accenture Professor and director of Regional Informatics, have been elected to the Institute of Medicine (IOM), the organization announced this week. Read MoreOct 21, 2013
-
Institute of Medicine honors Vanderbilt’s Clayton
Ellen Wright Clayton, M.D., J.D., the Craig-Weaver Professor of Pediatrics and professor of Law at Vanderbilt University, has won the David Rall Medal from the Institute of Medicine (IOM) for “exemplary” service to the institute. Read MoreOct 21, 2013
-
Weill Cornell’s Glimcher awarded Vanderbilt Prize
The 2013 Vanderbilt Prize in Biomedical Science has been awarded to Laurie Glimcher, M.D., Stephen and Suzanne Weiss Dean and professor of Medicine at Weill Cornell Medical College in New York City. Read MoreOct 17, 2013
-
Synthetic biology expert Collins set to speak at Vanderbilt
Boston University biomedical engineer and MacArthur Fellow James Collins, Ph.D., will lecture at 3:10 p.m. Oct. 23 in the Jacobs Believed in Me Auditorium, part of the Vanderbilt School of Engineering’s Featheringill Hall. Read MoreOct 17, 2013
-
New target for stopping inflammation
Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. Read MoreOct 11, 2013
-
Clinical and translational research highlighted at retreat
Kathleen Neuzil, M.D., MPH, known internationally for her efforts to expand vaccine access and delivery around the world, credited her Vanderbilt University mentors last week for guiding her to a career path that allowed her to “make a difference.” Read MoreOct 10, 2013
-
Discovery Lecturer makes case for stronger science
The occasional failings of science tend to draw big headlines — findings that can’t be replicated or increasing numbers of papers that are retracted because studies were improperly or even fraudulently conducted. Read MoreOct 10, 2013
-
VUMC poised to overcome health care challenges: Balser
While the national economy appears to be getting stronger, health care has entered a national recession, Jeff Balser, M.D., Ph.D., vice chancellor for Health Affairs and dean of the Vanderbilt University School of Medicine, told a packed audience of approximately 1,100 Vanderbilt faculty, staff and students in Langford Auditorium on Wednesday afternoon while making his annual State of the Medical Center address. Read MoreOct 3, 2013
-
VU’s technology commercialization efforts make strides
Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced. Read MoreSep 26, 2013